Lipella Pharmaceuticals Inc. (LIPO) — SC 13D/A Filings

All SC 13D/A filings from Lipella Pharmaceuticals Inc.. Browse 5 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (5)

  • Chancellor Updates Lipella Pharma 13D Filing — Oct 17, 2024 Risk: medium
    Michael B. Chancellor, through an amendment filed on October 17, 2024, has updated their Schedule 13D filing for Lipella Pharmaceuticals Inc. The filing indicat
  • Chancellor Amends Lipella Pharma Stake Filing — Aug 19, 2024 Risk: medium
    Michael B. Chancellor filed an amendment (No. 4) to Schedule 13D on August 19, 2024, regarding Lipella Pharmaceuticals Inc. The filing indicates a change in ben
  • Kaufman Amends Lipella Pharma Stake — May 6, 2024 Risk: medium
    On May 2, 2024, Jonathan H. Kaufman filed an amendment (Amendment No. 5) to Schedule 13D for Lipella Pharmaceuticals Inc. The filing indicates a change in the b
  • Kaufman Amends Lipella Pharma Stake — Mar 19, 2024 Risk: medium
    On March 15, 2024, Jonathan H. Kaufman filed an amendment (No. 4) to Schedule 13D for Lipella Pharmaceuticals Inc. This filing indicates a change in beneficial
  • Chancellor Amends Lipella Pharma 13D Filing — Mar 6, 2024 Risk: medium
    On March 4, 2024, Michael B. Chancellor filed an amendment (No. 2) to Schedule 13D for Lipella Pharmaceuticals Inc. The filing indicates a change in the reporti

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.